
M-Fost 500mg Injection
Marketer
Shantha Biotech
Salt Composition
Amifostine (500mg)
Overview M-Fost 500mg Injection
Amifostine 500mg injection combats radiotherapy-induced xerostomia in head and neck cancer patients. It mitigates cisplatin chemotherapy's nephrotoxicity. Administered intravenously (IV) under medical supervision, dosage and frequency are determined by your physician based on your treatment and may vary. Strict adherence to your doctor's instructions is crucial; improper use or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only upon your doctor's recommendation. Common side effects include nausea, vomiting, hypotension, somnolence, vertigo, and flushing; consult your doctor if these persist or worsen. Hydration prior to administration is recommended. Blood pressure monitoring precedes and continues every five minutes during IV infusion. Inform your physician of any cardiac conditions like arrhythmias or heart failure, or any concurrently used antimicrobial medications before treatment. Comprehensive disclosure of all medications to your healthcare provider is essential due to potential drug interactions.
Primary Ingredients of M-Fost 500mg Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of M-Fost 500mg Injection
Managing Xerostomia Following Head and Neck Cancer Radiotherapy
Major Benefits of M-Fost 500mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of M-Fost 500mg Injection:
- Nausea
- Vomiting
- Decreased blood pressure
- Hiccup
- Sleepiness
- Dizziness
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Fever
- Chills
How to use M-Fost 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How M-Fost 500mg Injection works:
M-Fost 500mg Injection neutralizes damaging byproducts generated by cisplatin chemotherapy or radiotherapy, thereby protecting affected tissues.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside M-Fost 500mg Injection has an unknown safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering M-Fost 500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The 500mg M-Fost injection is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
M-Fost 500mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Administering M-Fost 500mg Injection to individuals with impaired renal function is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of M-Fost 500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take M-Fost 500mg Injection :
NA
Facts to Know About M-Fost 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phosphorylated aminothiol |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Action Category | Kidney and Salivary Gland Protection |
